Encavis Valuation

Is CAS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CAS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CAS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CAS's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CAS?

Key metric: As CAS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CAS. This is calculated by dividing CAS's market cap by their current revenue.
What is CAS's PS Ratio?
PS Ratio6.1x
Sales€457.94m
Market Cap€2.80b

Price to Sales Ratio vs Peers

How does CAS's PS Ratio compare to its peers?

The above table shows the PS ratio for CAS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.6x
ESUN Edisun Power Europe
2.7xn/aCHF 43.7m
REHN Romande Energie Holding
1.3x1.5%CHF 1.1b
NEAG naturenergie holding
0.7x4.6%CHF 1.2b
BKW BKW
1.7x1.8%CHF 7.9b
CAS Encavis
6.1x8.4%CHF 2.8b

Price-To-Sales vs Peers: CAS is expensive based on its Price-To-Sales Ratio (6.1x) compared to the peer average (1.6x).


Price to Sales Ratio vs Industry

How does CAS's PS Ratio compare vs other companies in the European Renewable Energy Industry?

13 CompaniesPrice / SalesEstimated GrowthMarket Cap
CAS 6.1xIndustry Avg. 2.6xNo. of Companies13PS0246810+
13 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CAS is expensive based on its Price-To-Sales Ratio (6.1x) compared to the European Renewable Energy industry average (2.7x).


Price to Sales Ratio vs Fair Ratio

What is CAS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CAS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.1x
Fair PS Ratio5.1x

Price-To-Sales vs Fair Ratio: CAS is expensive based on its Price-To-Sales Ratio (6.1x) compared to the estimated Fair Price-To-Sales Ratio (5.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CAS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 20.08
CHF 16.60
-17.3%
4.9%CHF 18.87CHF 16.26n/a9
Nov ’25CHF 20.08
CHF 16.71
-16.8%
4.9%CHF 18.99CHF 16.37n/a9
Oct ’25CHF 20.08
CHF 16.77
-16.5%
7.9%CHF 19.48CHF 13.34n/a11
Sep ’25CHF 20.08
CHF 16.77
-16.5%
7.9%CHF 19.48CHF 13.34n/a11
Aug ’25CHF 20.08
CHF 16.77
-16.5%
7.9%CHF 19.48CHF 13.34n/a11
Jul ’25CHF 20.08
CHF 16.60
-17.3%
7.9%CHF 19.29CHF 13.21n/a11
Jun ’25CHF 20.08
CHF 17.03
-15.2%
7.6%CHF 19.78CHF 13.54n/a12
May ’25CHF 20.08
CHF 17.19
-14.4%
7.9%CHF 19.83CHF 13.58n/a12
Apr ’25CHF 20.08
CHF 17.32
-13.8%
8.1%CHF 19.88CHF 13.61n/a12
Mar ’25CHF 20.08
CHF 16.91
-15.8%
28.0%CHF 26.76CHF 10.99n/a12
Feb ’25CHF 20.08
CHF 17.65
-12.1%
25.6%CHF 26.45CHF 10.86n/a12
Jan ’25CHF 20.08
CHF 18.57
-7.5%
22.2%CHF 27.01CHF 11.58n/a12
Dec ’24CHF 20.08
CHF 18.57
-7.5%
22.2%CHF 27.01CHF 11.58n/a12
Nov ’24CHF 20.08
CHF 19.74
-1.7%
20.3%CHF 26.55CHF 11.38CHF 20.0811
Oct ’24CHF 20.08
CHF 20.99
+4.6%
15.4%CHF 27.09CHF 16.45CHF 20.0810
Sep ’24CHF 20.08
CHF 21.00
+4.6%
15.2%CHF 26.77CHF 16.25CHF 20.0811
Aug ’24CHF 20.08
CHF 21.20
+5.6%
14.8%CHF 26.91CHF 16.34CHF 20.0811
Jul ’24CHF 20.08
CHF 21.73
+8.2%
14.3%CHF 27.25CHF 16.55CHF 20.0811
Jun ’24CHF 20.08
CHF 21.73
+8.2%
14.3%CHF 27.25CHF 16.55CHF 20.0811
May ’24CHF 20.08
CHF 22.04
+9.7%
14.1%CHF 27.53CHF 16.72CHF 20.0811
Apr ’24CHF 20.08
CHF 22.31
+11.1%
14.2%CHF 27.91CHF 16.95CHF 20.0811
Mar ’24CHF 20.08
CHF 22.46
+11.9%
15.7%CHF 27.68CHF 16.81CHF 20.0810
Feb ’24CHF 20.08
CHF 22.47
+11.9%
16.6%CHF 28.06CHF 17.03CHF 20.089
Jan ’24CHF 20.08
CHF 23.35
+16.3%
13.7%CHF 28.13CHF 18.69CHF 20.089
Dec ’23CHF 20.08
CHF 23.84
+18.7%
15.6%CHF 29.58CHF 18.73CHF 20.089
Nov ’23CHF 20.08
CHF 23.56
+17.4%
14.9%CHF 29.32CHF 18.57CHF 20.0810

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies